• ABOUT
  • Company Overview
  • Management
  • Contact Information
• PRODUCTS
  • Product Strategy
  • Product Candidates
  • TRU-015 (Rheumatoid Arthritis)
  • SBI-087 (Rheumatoid Arthritis)
  • SBI-087 (Systemic Lupus Erythematosus)
  • TRU-016 (B-Cell Malignancies)
  • Product Technology
  • SMIP^™ Therapeutics
  • SCORPION^™ Therapeutics
  • TRU-ADhanCe^™ Technology
  • Patient Center
  • Rheumatoid Arthritis (RA)
  • Leukemia
  • Lymphoma
  • Lupus
• PARTNERSHIPS
  • Current Partnerships
• INVESTORS
  • Corporate Governance
  • Stock Information
  • Stock Performance
  • Historic Stock Lookup
  • Investment Calculator
  • Dividend History
  • Analyst Coverage
  • Financials
  • SEC Filings
  • Quarterly Results
  • Annual Reports
  • News & Events
  • Press Releases
  • Events & Presentations
  • Stockholder Services
  • Investor FAQs
  • Contact Us
• MEDIA
• CAREERS
  • Joining the Trubion Team
  • Job Openings
  • Culture and Benefits

Analyst Coverage

Print page     Email page

Trubion Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Trubion Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Trubion Pharmaceuticals, Inc. or its management. Trubion Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

Site Map | Terms of Use